Intellection and Bruker AXS Sign Strategic Collaboration Agreement
News Apr 18, 2008
Under this agreement, Intellection will expand its range of products and services, directly supplying XRF (X-ray fluorescence) and XRD (X-ray diffraction) systems from Bruker AXS to its customers. This will allow both companies to develop highly competitive global sales strategies.
"Intellection's own technological credentials are impeccable, with our QEMSCAN® solutions the international market leader across the resources sector," said Intellection CEO Calvin Treacy. "Bruker's XRD and XRF technologies complement QEMSCAN® analysis, making them an excellent business fit for us."
"Intellection is able to strongly endorse Bruker's products - the Bruker XFlash® SD detector currently forms part of our QEMSCAN® solution, and has delivered outstanding performance and reliability."
"The combination of fast, accurate particle analysis and identification technology provided by Intellection with Bruker AXS' X-ray diffraction, powered by the unique and unmatched TOPAS data evaluation software, is the most powerful method available for quantitative phase analysis in the fields of minerals and mining," said Bruker AXS Executive Vice President Dr. Frank Burgaezy.
The new strategic collaboration agreement extends the range of analytical processes offered to customers in the mining and upstream oil and gas sectors, allowing Intellection to provide the comprehensive range of advanced automated mineralogy solutions available from any supplier on a global basis.
It will also see Intellection and Bruker AXS undertake joint product development projects to add value to both companies' technologies.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
Highly Potent Active Pharmaceutical Ingredients (HPAPI)
May 21 - May 22, 2018